Current opinion in oncology
The evolving landscape of bispecific antibodies in the treatment of lung cancer.
Xuanhong Jin, Chang Chang, Fei Zhou
Published: 202510.1097/CCO.0000000000001206
Abstract
PURPOSE OF REVIEW: Lung cancer, the leading cause of cancer mortality, faces persistent challenges like resistance to targeted therapy and immunotherapy. This review comprehensively outlines the evolving role of bispecific antibodies (bsAbs), summari…
Preview only. Read the full abstract at the source